This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Masilukast

Mitsubishi Tanabe Pharma Corporation

Drug Names(s): MCC-847, ZD-3523

Description: MCC-847 is a leukotriene D4 receptor antagonist.

Deal Structure: Mitsubishi Tanabe has out licensed MCC-847 to SAMA Pharma.


Masilukast News


Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug